Greater Boston
Poised marketing communications executive, quickly able to build relationships, assess strategic business needs, and ensure execution to the finest detail while combining the art of innovation and creative storytelling. More than 20 years’ healthcare experience spanning marketing, digital and traditional communications, public relations, new product planning and commercialization, and sales in global and U.S. roles of increasing responsibility with many of the world’s largest, most well-known pharmaceutical companies and entrepreneurial biotech organizations. Experience spans all phases of product development, from phase 1 through launch and LCM. Consistently deliver excellence and impact in each role and across functional areas, earning various industry and corporate recognition awards. MOAS / COMPOUNDS PARPi (ZEJULA, niraparib), aBCMA (BLENREP, belantimab mafodotin), PD-1 (JEMPERLI, dostarlimab), NK-1 antagonist (Varubi, rolapatant), PD-L1 (BAVENCIO, avelumab), bi-functional TGFβ/aPD-L1 (M7824), c-Meti (tepotinib), HAP (evofosfamide), PI3Ki (COPIKTRA, duvelisib), taxanes (JEVTANA, cabazitaxel/TAXOTERE), BCR-ABLi (ICLUSIG, ponatinib), mTOR (ridaforolimus), HSP90i (retaspimycin HCL), autologous therapeutic cancer vaccine (oncophage) TUMOR TYPES Solid Tumors: ovarian, endometrial, sarcoma, pancreatic, NSCLC, HCC, CRPC, RCC, Melanoma, GBM, BC Hematologic Malignancies: multiple myeloma, CML, CLL, FL, DLBCL, T-cell malignancies THERAPEUTIC AREAS Oncology (solid tumor/hematologic malignancies), cardiology*, neurology*, dermatology*, antivirals* (*as sales representative)
-Oversee development of all programs and tactics supporting brand strategy across cross functional teams delivering in-line market success, indication expansion and launch readiness planning -Create, monitor, and report on all relevant strategies, insights and metrics of U.S. brand performance, global development strategy and launch progress to executive leadership team -Successfully rebuilt and led marketing team of 10 critical roles including brand marketers (HCP/Consumer), commercial launch lead, Peer to Peer, Digital marketing, Field Marketers & Congress Planning supporting MONJUVI and launch readiness for pelabresib -Key member of U.S. Leadership Team reporting to U.S. GM
•Define communication strategies for, and oversees execution of, pipeline data announcements, product approvals and launches, and other milestones for the US business unit •Key member of oncology business unit’s Executive Leadership Team; contribute to key strategic decisions necessary for relaunch of successful business unit, including integration of TESARO organization into GSK Oncology, new GSK Oncology go-to-market model, business prioritization, and culture •In 18 months, delivered 5 oncology FDA approvals, exceeding all media benchmarks; helped organization devise and adapt to new ways of working during COVID-19 pandemic •Expand brand adoption through development and execution of strategic public relations strategies integrating social platforms, digital, traditional media, live sponsored programming, which set new standards for GSK US Pharmaceuticals business •Responsible for business unit internal communications, external risk-mitigation strategies, and engagement of its 400+ employees in business unit’s mission •Develop GSK US Oncology’s foundational, integrated messaging platform and external executive engagement strategy through social, executive speaking engagements, and earned media partnerships in order to differentiate and solidify GSK as leader in oncology space
•Established multichannel marketing and digital ecosystem including policies and processes for TESARO corporate organization and commercial brands •Established digital analytics strategy, goals and reporting to drive brand impact via integrated engagement throughout the customer journey •Responsible for building foundational ZEJULA digital media strategy and analytics across various channels, including website architecture/UX and SEO/SEM, CRM, social media channel and campaign development, display and PR to drive adoption •Built TESARO’s brand PR function, creating and launching 2 award-winning, brand-supportive, omnichannel, celebrity PR campaigns to drive awareness and adoption of new treatment approaches for ovarian cancer •Increased TESARO/ZEJULA's presence and SOV with innovative data-visualization tools, mat releases/op-eds, industry interviews with oncology trades •Led strategic corporate repositioning, creative development, and digital execution for TESARO’s rebranding efforts, reinforcing our unconditional care for customers and cancer communities
-Represented the global business franchise on cross-functional teams within oncology franchise to ensure commercial aspect are integrated into development strategies (R&D, manufacturing, CDx, market access/pricing etc) -Interpreted, analyzed and translated scientific clinical data of pipeline assets and competition and make strategic recommendations beginning in early development through peri-luanch phases of assets to ensure early commercial differentiation -Led all commercial aspects of early strategic plan including development of market and opportunity assessments, disease area understanding, competitive landscapes, white space analyses and unmet needs -Led the development of brand vision, early positioning, strategic scientific platform development and target product profiles (TPPs) and forecasts for designated programs -Partnered with market research , forecasting, analytics, CI and R&D to develop and maintained competitive landscape assessments; based on commercial implications, recommended strategic adjustment in order to sustain competitive edge
•Act as commercial marketing lead accountable for the global launch readiness of evofosfamide, a hypoxia activated prodrug, across multiple indications including advanced soft tissue Sarcoma and advanced pancreatic cancer •Lead the Global Brand Strategy Launch sub-team, and provide commercial leadership on product core teams including: Global Product Team (GPT), Commercial Launch Team (CLT), CDP and iDP strategy & development, manufacturing launch team, market access & pricing team and label development •Responsible for all brand development initiatives including vision, positioning, messaging, market development strategy and campaign, brand campaign, branding and logo development •Marketing lead for the development of the annual brand plan and associated operating plan supporting both launch indications •Responsible for the personal and non-personal promotional efforts for professional integrated multi-channel marketing strategies (congress, media, digital and print) •Collaborate with market research to define and drive the development of the brand's strategic plans in order to uncover unmet clinical needs, drivers/barriers and gain understanding of market dynamics •Work closely with key market and regional teams (US, Europe, APAC, LATAM, ITC) to gather input and local insights and incorporate feedback into global strategies •Represent brand strategy and market dynamics to Senior Management, functional and/or product teams and help to interpret data producing sound decision-making •Manages the A&P budget of $12.5M, including strategic resource allocation across the global oncology business franchise